Dr. Brian M. Benway, MD

Dr. Benway practices at Mercy Hospital St Louis - Oncology and Hematology Patients First - HOPD in Washington, Missouri.

Dr. Benway's NPI, 1174573125, was assigned on May 11, 2006. Dr. Benway graduated from Indiana University School Of Medicine in 2003. Dr. Benway holds California license C135843.

Dr. Benway's primary practice is Mercy Hospital St Louis - Oncology and Hematology Patients First - HOPD, at 901 Patients First Dr, Washington, MO 63090.

Dr. Benway's primary practice is Mercy Hospital St Louis - Oncology and Hematology Patients First - HOPD in Washington, Missouri. Dr. Benway is also affiliated with Mercy Hospital Washington. The medical group on file is Mercy Clinic Urology - Patients First Drive. Dmand AI also links Dr. Benway to 3 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account. Dr. Benway's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benway practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Benway's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Benway is board certified in urology by the American Board of Urology. Dmand AI has Dr. Benway's licenses on file in 3 states: California, Missouri and Wisconsin.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, urinary endoscopy and urine flow blockage among the conditions Dr. Benway treats.

CMS data shows 437 Medicare services from Dr. Benway across 7 procedure codes in 2024, for 335 Medicare patients. Medicare paid $45,262 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 335 Medicare patients who saw Dr. Benway in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 5.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benway's median patient age at 69, with 24% women.

In 2024, Dr. Benway wrote 278 Medicare Part D claims for 97 patients. 90% of them were for generic drugs. CMS names the drug for 190 of them, across 8 drugs with 11 or more claims each, at $11,246 in total drug cost. In 2023, CMS named 181 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Benway for performance year 2024, reported as part of a group. Dr. Benway accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benway as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 37 papers to Dr. Benway, published from 2009 to 2016. 2009 was the busiest year, with 3. The most frequent topics are Nephrectomy, Kidney Neoplasms and Robotics. Dr. Benway has published most often in J Endourol. Dr. Benway's most frequent co-authors are Sam B. Bhayani, MD, Robert S. Figenshau, MD and Alana Christina Desai, MD.

Dmand AI links Dr. Benway to 1 clinical trial. Conditions studied include Urinary Calculi and Calculi.

CMS Open Payments shows 47 general payments to Dr. Benway from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 31% of the total. Intuitive Surgical, Inc. paid the most, $3,660.

Dmand AI lists 1 award for Dr. Benway, most recently CMS Stage 1 EHR in 2012.

Dr. Benway graduated from Indiana University School Of Medicine in 2003. Dr. Benway is a member of AUA and Endourological Society.

Dr. Benway is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.